more general categories |
information about this item |
|
1. Human Genes |
 |
 |
|
1. Human Genes |
|
|
aldo-keto reductase family 1, member C1 [HGNC:AKR1C1] (148) |
|
|
aldo-keto reductase family 1, member C2 [HGNC:AKR1C2] (134) |
|
|
aldo-keto reductase family 1, member C3 [HGNC:AKR1C3] (128) |
|
|
|
|
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 7 [HGNC:CFTR] (131) |
|
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) [HGNC:CFTR] (131) |
|
 |
2. Interaction: Human Genes and Chemicals |
 |
 |
|
2. Interaction: Human Genes and Chemicals |
|
|
cotreatment (1499) |
|
|
activity (2549) |
|
|
reaction (3393) |
|
|
activity (2865) |
|
|
transport (399) |
|
 |
A. Anatomy |
 |
 |
|
A. Anatomy |
|
|
|
|
|
|
|
|
|
|
|
Congenital bilateral aplasia of vas deferens [MESH:C535984] (194) |
|
 |
C04. Neoplasms |
 |
 |
|
C04. Neoplasms |
|
|
|
|
|
|
|
|
Polycystic Ovary Syndrome [MESH:D011085] (2186) |
|
|
|
|
|
|
|
|
|
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
|
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
|
|
|
|
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
|
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
Tongue Neoplasms [MESH:D014062] (1518) |
|
|
Dermatopathia pigmentosa reticularis [MESH:C535374] (38) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carcinoma, Non-Small-Cell Lung [MESH:D002289] (3540) |
|
|
|
|
|
|
|
|
Endometrial Neoplasms [MESH:D016889] (1987) |
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
|
|
|
Cell Transformation, Neoplastic [MESH:D002471] (3389) |
|
 |
C05. Musculoskeletal Diseases |
 |
 |
|
C05. Musculoskeletal Diseases |
|
|
|
|
|
|
|
|
Osteoarthritis [MESH:D010003] (1743) |
|
|
Osteoarthritis [MESH:D010003] (1743) |
|
 |
C06. Digestive System Diseases |
 |
 |
|
C06. Digestive System Diseases |
|
|
|
|
|
|
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
|
|
|
|
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Cystic Fibrosis [MESH:D003550] (760) |
|
|
|
|
|
Hereditary pancreatitis [MESH:C537262] (234) |
|
 |
C07. Stomatognathic Diseases |
 |
 |
|
C07. Stomatognathic Diseases |
|
|
|
|
|
|
|
|
Tongue Neoplasms [MESH:D014062] (1518) |
|
|
Tongue Neoplasms [MESH:D014062] (1518) |
|
 |
C08. Respiratory Tract Diseases |
 |
 |
|
C08. Respiratory Tract Diseases |
|
|
|
|
|
|
|
|
Bronchiectasis With Or Without Elevated Sweat Chloride 1 [MESH:C567618] (217) |
|
|
Cystic Fibrosis [MESH:D003550] (760) |
|
|
|
|
|
Carcinoma, Non-Small-Cell Lung [MESH:D002289] (3540) |
|
|
Rhinitis [MESH:D012220] (1134) |
|
|
Sinusitis [MESH:D012852] (469) |
|
|
Ige Responsiveness, Atopic [MESH:C564133] (267) |
|
|
Rhinitis [MESH:D012220] (766) |
|
|
Sinusitis [MESH:D012852] (469) |
|
|
|
|
|
|
|
|
|
|
|
Carcinoma, Non-Small-Cell Lung [MESH:D002289] (3540) |
|
 |
C09. Otorhinolaryngologic Diseases |
 |
 |
|
C09. Otorhinolaryngologic Diseases |
|
|
|
|
|
Rhinitis [MESH:D012220] (1134) |
|
|
Sinusitis [MESH:D012852] (469) |
|
 |
C12. Male Urogenital Diseases |
 |
 |
|
C12. Male Urogenital Diseases |
|
|
Congenital bilateral aplasia of vas deferens [MESH:C535984] (194) |
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
|
|
|
Azoospermia [MESH:D053713] (1052) |
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
|
|
|
Kidney Papillary Necrosis [MESH:D007681] (46) |
|
|
|
|
|
Glomerulosclerosis, Focal Segmental [MESH:D005923] (1754) |
|
|
Acute Kidney Injury [MESH:D058186] (4142) |
|
|
Proteinuria [MESH:D011507] (3293) |
|
 |
C13. Female Urogenital Diseases and Pregnancy Complications |
 |
 |
|
C13. Female Urogenital Diseases and Pregnancy Complications |
|
|
|
|
|
Endometriosis [MESH:D004715] (2461) |
|
|
|
|
|
|
|
|
Polycystic Ovary Syndrome [MESH:D011085] (2186) |
|
|
|
|
|
Endometrial Neoplasms [MESH:D016889] (1984) |
|
|
|
|
|
|
|
|
Endometrial Neoplasms [MESH:D016889] (1989) |
|
|
|
|
|
Kidney Papillary Necrosis [MESH:D007681] (46) |
|
|
|
|
|
Glomerulosclerosis, Focal Segmental [MESH:D005923] (1754) |
|
|
Acute Kidney Injury [MESH:D058186] (4142) |
|
|
Proteinuria [MESH:D011507] (3293) |
|
 |
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
 |
 |
|
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
|
|
|
|
|
|
|
|
|
|
|
Naegeli syndrome [MESH:C538331] (38) |
|
|
|
|
|
Naegeli syndrome [MESH:C538331] (38) |
|
|
|
|
|
Epidermolysis Bullosa Simplex, Autosomal Recessive [MESH:C563408] (38) |
|
|
Cystic Fibrosis [MESH:D003550] (760) |
|
|
|
|
|
Naegeli syndrome [MESH:C538331] (38) |
|
|
|
|
|
Epidermolysis Bullosa Simplex, Autosomal Recessive [MESH:C563408] (38) |
|
|
Naegeli syndrome [MESH:C538331] (38) |
|
|
Cystic Fibrosis [MESH:D003550] (760) |
|
 |
C17. Skin and Connective Tissue Diseases |
 |
 |
|
C17. Skin and Connective Tissue Diseases |
|
|
|
|
|
|
|
|
|
|
|
Dermatopathia pigmentosa reticularis [MESH:C535374] (38) |
|
|
|
|
|
Naegeli syndrome [MESH:C538331] (38) |
|
|
Dermatopathia pigmentosa reticularis [MESH:C535374] (38) |
|
|
|
|
|
Dermatopathia pigmentosa reticularis [MESH:C535374] (38) |
|
|
|
|
|
Naegeli syndrome [MESH:C538331] (38) |
|
|
|
|
|
Epidermolysis Bullosa Simplex, Autosomal Recessive [MESH:C563408] (38) |
|
|
|
|
|
Naegeli syndrome [MESH:C538331] (38) |
|
|
|
|
|
Epidermolysis Bullosa Simplex, Autosomal Recessive [MESH:C563408] (38) |
|
|
Naegeli syndrome [MESH:C538331] (38) |
|
|
Blister [MESH:D001768] (93) |
|
|
|
|
|
Epidermolysis Bullosa Simplex, Autosomal Recessive [MESH:C563408] (38) |
|
|
Dermatopathia pigmentosa reticularis [MESH:C535374] (38) |
|
|
|
|
|
Naegeli syndrome [MESH:C538331] (38) |
|
 |
C18. Nutritional and Metabolic Diseases |
 |
 |
|
C18. Nutritional and Metabolic Diseases |
|
|
|
|
|
Obesity [MESH:D009765] (4462) |
|
 |
C19. Endocrine System Diseases |
 |
 |
|
C19. Endocrine System Diseases |
|
|
|
|
|
|
|
|
|
|
|
Polycystic Ovary Syndrome [MESH:D011085] (2186) |
|
 |
C20. Immune System Diseases |
 |
 |
|
C20. Immune System Diseases |
|
|
|
|
|
|
|
|
|
|
|
Ige Responsiveness, Atopic [MESH:C564133] (267) |
|
 |
C22. Animal Diseases |
 |
 |
|
C22. Animal Diseases |
|
|
Disease Models, Animal [MESH:D004195] (2058) |
|
 |
C23. Pathological Conditions, Signs and Symptoms |
 |
 |
|
C23. Pathological Conditions, Signs and Symptoms |
|
|
Blister [MESH:D001768] (93) |
|
|
Dermatopathia pigmentosa reticularis [MESH:C535374] (38) |
|
|
Hernia, Diaphragmatic [MESH:D006548] (2647) |
|
|
Necrosis [MESH:D009336] (4019) |
|
|
|
|
|
Cell Transformation, Neoplastic [MESH:D002471] (3389) |
|
|
|
|
|
|
|
|
Obesity [MESH:D009765] (4454) |
|
|
Proteinuria [MESH:D011507] (3293) |
|
 |
C25. Chemically-Induced Disorders |
 |
 |
|
C25. Chemically-Induced Disorders |
|
|
Substance-Related Disorders [MESH:D019966] (6308) |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
 |
D02. Organic Chemicals |
 |
 |
|
D02. Organic Chemicals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ortho-Aminobenzoates [MESH:D062367] (164) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ortho-Aminobenzoates [MESH:D062367] (164) |
|
 |
D27. Chemical Actions and Uses |
 |
 |
|
D27. Chemical Actions and Uses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-Inflammatory Agents, Non-Steroidal [MESH:D000894] (115) |
|
|
|
|
|
Anti-Inflammatory Agents, Non-Steroidal [MESH:D000894] (115) |
|
|
Anti-Inflammatory Agents, Non-Steroidal [MESH:D000894] (115) |
|
|
Calcium Channel Blockers [MESH:D002121] (34) |
|
 |